Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 01:05pm CEST

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
[email protected]
Vice President and Chief Financial Officer


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
06/23 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Submission of Matters to..
06/23 NATUS MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-..
06/19 NATUS MEDICAL : Combine Solicitation - 65-- BRAND NAME OR EQUAL Smart Balance Sy..
05/30 Natus to Present at Jefferies 2017 Healthcare Conference
05/11 Natus Medical to Host Analyst Day on June 22nd
05/08 NATUS MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
05/05 EEG-EMG Equipment Market 2017 - Zynex, Medtronic, Natus Medical, Masimo Corpo..
04/26 NATUS MEDICAL INC (NASDAQ : BABY) reported earnings of $0.30 per share missing W..
04/26 NATUS MEDICAL : misses 1Q profit forecasts
04/26 Natus Medical Announces First Quarter 2017 Financial Results
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/22DJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06/23 Natus Medical Incorporated (BABY) Investor Presentation - Slideshow
06/19 DAILY INSIDER RATINGS ROUND UP 6/15/ : Fosl, le
06/12 NATUS MEDICAL : Not Cheap, But Still Attractive
06/07 Natus Medical (BABY) Presents At Jefferies 2017 Global Healthcare Conference ..
04/26 Natus Medical's (BABY) CEO Jim Hawkins on Q1 2017 Results - Earnings Call Tra..
Advertisement
Financials ($)
Sales 2017 505 M
EBIT 2017 59,4 M
Net income 2017 29,9 M
Debt 2017 37 027 M
Yield 2017 -
P/E ratio 2017 38,25
P/E ratio 2018 24,23
Capi. / Sales 2017 75,7x
Capi. / Sales 2018 2,30x
Capitalization 1 181 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 48,0 $
Spread / Average Target 34%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer, EVP & IR Contact
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC2.59%1 173
THERMO FISHER SCIENTIF..22.77%68 244
DANAHER9.80%60 686
BOSTON SCIENTIFIC CORP..28.16%38 480
INTUITIVE SURGICAL48.29%34 960
ROYAL PHILIPS13.10%34 550
More Results